Earlier studies demonstrated that increased BCR values correlate with striatal atrophy and clinical severity in HD patients, making it a useful tool for distinguishing affected individuals from controls and for monitoring disease progression over time [3, 6].​ Similarly, the FCR, which incorporates both frontal horn width and bicaudate distance, was introduced to enhance sensitivity to early frontostriatal changes. The gene discussed is BCR; the disease is Huntington disease.